← Back to Search

Local Anesthetic

Pre-operative femoral nerve catheter for Postoperative Pain

Phase 3
Waitlist Available
Research Sponsored by Rothman Institute Orthopaedics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 weeks
Awards & highlights

Summary

This trial is evaluating whether a single injection of liposomal bupivacaine (Exparel) into the adductor canal is a safe and effective alternative to a femoral nerve catheter for post-operative pain control in patients undergoing ACL reconstruction.

Eligible Conditions
  • Anterior Cruciate Ligament (ACL)
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient satisfaction
Post operative pain management

Trial Design

2Treatment groups
Active Control
Group I: Pre-operative femoral nerve catheterActive Control4 Interventions
participants undergoing ACL reconstruction surgery will receive a femoral prior to their surgery
Group II: Pre-operative adductor canal block with liposomal bupivacaineActive Control4 Interventions
participants undergoing ACL reconstruction surgery will receive a nerve block using liposomal Bupivacaine (Exparel)

Find a Location

Who is running the clinical trial?

Rothman Institute OrthopaedicsLead Sponsor
122 Previous Clinical Trials
21,550 Total Patients Enrolled
3 Trials studying Postoperative Pain
523 Patients Enrolled for Postoperative Pain
~41 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top